Effect of Early Use of Enwolocumab on Cardiovascular Events in Patients with Extremely-High-Risk Atherosclerotic Cardiovascular Disease after Percutaneouscoronary Intervention
-
Published:2023
Issue:02
Volume:13
Page:1346-1355
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Subject
General Engineering
Reference29 articles.
1. Tsao, C.W., Aday, A.W., Almarzooq, Z.I., et al. (2022) Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association. Circulation, 145, e153-e639.
2. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
3. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention
4. 张峰, 金琴花. 急性冠状动脉综合征患者血脂管理临床路径专家共识[J]. 中国循环杂志, 2020, 35(10): 941-947.
5. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献